[1] Karapinar DY,Karada? N,Yazici P,et al.Trichosporon asahii,sepsis,and secondary hemophagocytic lymphohistiocytosis in children with hematologic malignancy[J].Pediatr Hematol Oncol,2014,31(3):282-284.
[2] Miura Y,Kaneko M,Nishizawa M,et al.Breakthrough infection of Trichosporon asahii in a patient with chronic lymphocytic leukemia[J].Int J Hematol,2007,85(2):177-178.
[3] Ozkaya-Parlakay A,Karadag-Oncel E,Cengiz AB,et al.Trichosporon asahii sepsis in a patient with pediatric malignancy[J].Wei mian yu gan ran za zhi,2016,49(1):146-149.
[4] Takamura S,Oono T,Kanzaki H,et al.Disseminated trichosporonosis with Trichosporon asahii[J].Eur J Dermatol,1999,9(7):577-579.
[5] Yildiran A,Kücük dük S,Saniç A,et al.Disseminated Trichosporon asahii infection in a preterm[J].Am J Perinatol,2003,20(5):269-271.
[6] Sun W,Su J,Xu S,et al.Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients:genotypes,virulence factors and antifungal susceptibility testing[J].J Med Microbiol,2012,61(Pt 12):1750-1757.
[7] Almeida AA,Crispim Bdo A,Grisolia AB,et al.Genotype,antifungal susceptibility,and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients[J].Rev Argent Microbiol,2016,48(1):62-66.
[8] Liao Y,Yang S,Cong L,et al.In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates[J].Antimicrob Agents Chemother,2014,58(12):7615-7616.
[9] Xia Z,Yang R,Wang W,et al.Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients[J].Mycopathologia,2012,173(2-3):127-133.
[10] Kerr JR.Suppression of fungal growth exhibited by Pseudomonas aeruginosa[J].J Clin Microbiol,1994,32(2):525-527.
[11] Bandara HM,K Cheung BP,Watt RM,et al.Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development[J].Molecular Oral Microbiology,2012,28(1):54-69. |